{
    "title": "110_s1951",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Fair Medicaid Drug Payment Act of \n2007''.\n\nSEC. 2. PROVIDING ADEQUATE PHARMACY REIMBURSEMENT UNDER MEDICAID.\n\n    (a) Pharmacy Reimbursement Limits.--\n            (1) In general.--Section 1927(e) of the Social Security Act \n        (42 U.S.C. 1396r-8(e)) is amended--\n                    (A) in paragraph (4), by striking ``(or, effective \n                January 1, 2007, two or more)''; and\n                    (B) by striking paragraph (5) and inserting the \n                following:\n            ``(5) Use of amp in upper payment limits.--The Secretary \n        shall calculate the Federal upper reimbursement limit \n        established under paragraph (4) as no less than 300 percent of \n        the weighted average (determined on the basis of utilization) \n        of the most recent average manufacturer prices for \n        pharmaceutically and therapeutically equivalent multiple source \n        drug products that are available for purchase by retail \n        community pharmacies on a nationwide basis. The Secretary shall \n        implement a smoothing process for average manufacturer prices \n        to ensure that Federal upper reimbursement limits do not vary \n        significantly from month to month as a result of rebates, \n        discounts, and other pricing practices. Such process shall be \n        similar to the smoothing process used in determining the \n        average sales price of a drug or biological under section \n        1847A.''.\n            (2) Definition of amp.--Section 1927(k)(1) of such Act (42 \n        U.S.C. 1396r-8(k)(1)) is amended--\n                    (A) in subparagraph (A), by striking ``by'' and all \n                that follows through the period and inserting ``by--\n                            ``(i) wholesalers for drugs distributed to \n                        retail community pharmacies; and\n                            ``(ii) retail community pharmacies that \n                        purchase drugs directly from the \n                        manufacturer.''; and\n                    (B) in subparagraph (B)--\n                            (i) in the subparagraph heading, by \n                        striking ``extended to wholesalers'' and \n                        inserting ``and other payments''; and\n                            (ii) by striking ``regard to'' and all that \n                        follows through the period and inserting \n                        ``regard to--\n                            ``(i) customary prompt pay discounts \n                        extended to wholesalers;\n                            ``(ii) bona fide service fees paid by \n                        manufacturers to wholesalers or retail \n                        community pharmacies, including (but not \n                        limited to) distribution service fees, \n                        inventory management fees, product stocking \n                        allowances, and fees associated with \n                        administrative services agreements and patient \n                        care programs (such as medication compliance \n                        programs and patient education programs);\n                            ``(iii) reimbursement by manufacturers for \n                        recalled, damaged, expired, or otherwise \n                        unsalable returned goods, including (but not \n                        limited to) reimbursement for the cost of the \n                        goods and any reimbursement of costs associated \n                        with return goods handling and processing, \n                        reverse logistics, and drug destruction;\n                            ``(iv) payments received from, and rebates \n                        or discounts provided to, pharmacy benefit \n                        managers, managed care organizations, health \n                        maintenance organizations, insurers, hospitals, \n                        clinics, mail order pharmacies, long term care \n                        providers, manufacturers, or any other entity \n                        that does not conduct business primarily as a \n                        wholesaler or a retail community pharmacy;\n                            ``(v) any payments made by manufacturers \n                        that are associated with drugs dispensed by \n                        retail community pharmacies; and\n                            ``(vi) any other discounts, rebates, \n                        payments, or other financial transactions that \n                        are not received by, paid by, or passed through \n                        to, retail community pharmacies.''.\n            (3) Definition of multiple source drug.--Section \n        1927(k)(7)(A)(i) of such Act (42 U.S.C. 1396r-8(k)(7)(A)(i)) is \n        amended--\n                    (A) in the matter preceding subclause (I), by \n                striking ``there at least 1 other drug product'' and \n                inserting ``there are at least 2 other drug products''; \n                and\n                    (B) in subclauses (I), (II), and (III), by striking \n                ``is'' each place it appears and inserting ``are''.\n            (4) Definitions of retail community pharmacy; wholesaler.--\n        Section 1927(k) of such Act (42 U.S.C. 1396r-8(k)) is amended \n        by adding at the end the following new paragraphs:\n            ``(10) Retail community pharmacy.--The term `retail \n        community pharmacy' means a traditional independent pharmacy, \n        traditional chain pharmacy, a supermarket pharmacy, or a mass \n        merchandiser pharmacy that is licensed as a pharmacy by a State \n        and that dispenses medications to the general public at retail \n        prices. Such term does not include a pharmacy that dispenses \n        prescription medications to patients primarily through the \n        mail, nursing home pharmacies, long-term care facility \n        pharmacies, hospital pharmacies, clinics, charitable or not-\n        for-profit pharmacies, government pharmacies, or pharmacy \n        benefit managers.\n            ``(11) Wholesaler.--The term `wholesaler' means a drug \n        wholesaler that is licensed as a wholesaler by a State and that \n        is engaged in wholesale distribution of prescription drugs to \n        retail community pharmacies, including (but not limited to) \n        manufacturers, repackers, own-label distributors, private-label \n        distributors, jobbers, brokers, warehouses (including \n        manufacturer's and distributor's warehouses, chain drug \n        warehouses, and wholesale drug warehouses) independent \n        wholesale drug traders, and retail pharmacies that conduct \n        wholesale distributions.''.\n    (b) Requirements of Prior Authorization Programs.--Section \n1927(d)(5) of such Act (42 U.S.C. 1396r-8(d)(5)) is amended--\n            (1) in the matter preceding subparagraph (A), by striking \n        ``of the drug before its dispensing for any medically accepted \n        indication (as defined in subsection (k)(6)) only if the system \n        providing for such approval'' and inserting ``by the State of \n        the use of the drug before its dispensing for any medically \n        accepted indication (as defined in subsection (k)(6)). A State \n        plan under this title shall, as a condition of coverage or \n        payment for a covered outpatient drug for which Federal \n        financial participation is available in accordance with this \n        section, subject to prior authorization all covered outpatient \n        drug products that are innovator multiple source drugs if such \n        drug products are more expensive than other biologically and \n        therapeutically equivalent drug products that are available for \n        purchase in that State by retail community pharmacies. The \n        system providing for such approval shall'';\n            (2) in each of subparagraphs (A) and (B), by striking \n        ``provides'' and inserting ``provide'';\n            (3) by redesignating subparagraphs (A) and (B) (as so \n        amended) as subparagraphs (C) and (D), respectively; and\n            (4) by inserting before subparagraph (C) (as so \n        redesignated), the following new subparagraphs:\n                    ``(A) require the prescriber to request prior \n                authorization by substantiating the medical necessity \n                of dispensing the covered outpatient drug as opposed to \n                dispensing a substitute covered outpatient drug;\n                    ``(B) require that a prior authorization number \n                assigned to the approved request by the State be \n                included on the order for the covered outpatient drug \n                issued by the prescriber or relayed to the dispensing \n                pharmacist by the prescriber if the prescription is \n                orally transmitted;''.\n    (c) Disclosure of Price Information to the Public.--Section \n1927(b)(3) of such Act (42 U.S.C. 1396r-8(b)(3)) is amended--\n            (1) in subparagraph (A)--\n                    (A) in clause (i), in the matter preceding \n                subclause (I), by inserting ``month of a'' after \n                ``each''; and\n                    (B) in the last sentence, by striking ``and \n                shall,'' and all that follows through the period; and\n            (2) in subparagraph (D)--\n                    (A) in clause (iii), by inserting ``and'' after the \n                comma;\n                    (B) in clause (iv), by striking ``, and'' and \n                inserting a period; and\n                    (C) by striking clause (v).\n    (d) Technical Amendment.--Section 1927(d)(1) of such Act (42 U.S.C. \n1396r-8(d)(1)) is amended in the paragraph heading by inserting ``and \nmandatory'' after ``permissible''.\n    (e) Effective Date.--\n            (1) In general.--Except as provided in paragraph (2), the \n        amendments made by this section shall take effect as if \n        included in the enactment of the Deficit Reduction Act of 2005 \n        (Public Law 109-171).\n            (2) Exception.--The amendments made by subsection (b) shall \n        take effect on the date that is 180 days after the date of \n        enactment of this Act."
}